Drawing for SOLVOPRET

USPTO serial 79002150

SOLVOPRET

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
STRZYZ, KAREN
Law office
TMO LAW OFFICE 112 - SENIOR ATTORNEY

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOLVOPRET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003essential oils for use in the manufactures of scented products; plant extracts and flavourings in liquid, solid or gaseous form for use in the manufactures of cosmetics, hair lotions, perfumes and eau de toilettes; tinctures for use in the manufactures of cosmetics, hair lotions, perfumes and eau de toilettes; cosmetics, hair lotions; dentifrices, namely, toothpasteACTIVE
005pharmaceutical preparations for use in the treatment of urinary obstruction, chronical venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, diseases relating to the bronchi inflammations of the upper and lower respiratory organs, fever, cough, cold, pain; pharmaceutical preparations, namely, plant extracts for use in the treatment of angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood preasure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy; pharmaceutical preparations, namely, plant extracts for use as an antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer; hemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparation, non-narcotic analgesic, throat lozenges; medicaments for the treatment of gynecological disorders, menstruation circulation regulating tablets, drugs for circulatory organs, hormone preparations, medicinal agents for urinary, genital and anal organs, medicinal agents for blood conditions, gynecologic oriental medicine, pill for treating dizziness, immune regulator; pharmaceutical preparations and medicines for the treatment of womens' diseases, namely, migraine and depression; medicines for the treatment of breast pain; medicines for treating climacteric complaints, premenstrual syndrome and dysmenorrhea; pharmaceutical preparations and medicines for the treatment of gynecological disorders affecting menstruation, sterility, menstruous syndromes, mammae, mastopathie, mastodynia, climacteric complaints, premenstrual syndrome, dysmenorrhea; food supplements containing plant extracts, food supplements derived from plants or plant extracts; dietetic substances derived from plants, adapted for medical use, namely food for medically restricted diets, food for diabetics, dietary food supplements, and vitamin and mineral supplements, herb teas for medicinal purposes and medicinal teas, in class 5 healthcare preparations for medical use, in international class 05; medical plasters, bandages and gauze for dressings, wound and surgical dressings; all purpose desinfectants; plant extracts, namely, food supplements containing plant extracts, food supplements derived from plants or plant extracts in international class 05; tinctures and flavourings in liquid, solid or gaseous form for pharmaceutical preparations and for dietic products for medical purposes in international class 05ACTIVE
029plant extracts being foodstuffs or food supplements or used for foodstuffs or food supplements not for medical purposesACTIVE
030plant extracts being foodstuffs or food supplements or used for foodstuffs or food supplements not for medical purposes; food flavourings in liquid, solid or gaseous form for food, food-supplements and foodstuffs; herbal teasACTIVE
031living plants and living parts of plants; dried plants; unprocessed herbsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2005DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 10, 2005OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 20, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 20, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 28, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 27, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 5, 2005NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Feb 1, 2005MAILPAPER RECEIVED
Jan 28, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2005MAILPAPER RECEIVED
Oct 29, 2004RFNTREFUSAL PROCESSED BY IB
Sep 17, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2004DOCKASSIGNED TO EXAMINER
May 20, 2004NWAPNEW APPLICATION ENTERED
May 20, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance